Hair regrowth continues to improve at 76 weeks with baricitinib for severe alopecia

Continuous treatment with Eli Lilly’s baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the

, held from March 8 to 12 in San Diego.

…